GGrantIndex
Sort

261,768 grants matching gene therapy

Developing a Clinically Relevant Radiosensitizer for Temozolomide-resistant Gliomas

$1,007,612
Thomas C Chen · Neonc Technologies, Inc. · R42 · FY2025 · CA

Physiology, Psychology, and Genetics of Obesity

$1,007,535
Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD

Etiological Studies of Gastric Carcinoma

$1,007,531
Keith T Wilson · Vanderbilt University Medical Center · P01 · FY2019 · CA

Development of Transplant Strategies Uniquely Responsive to the Needs of Children

$1,007,528
Allan D. Kirk · Emory University · U01 · FY2009 · AI

Probing Systems-Level Function of Fronto-Temporal

$1,007,436
New York University · P50 · FY2005 · MH

Late Effects of Treatment in Wilms Tumor Survivors and Offspring

$1,007,340
Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA

Autoimmunity: Mechanisms of Unresponsiveness

$1,007,289
Charles Garrison Fathman · Stanford University · P01 · FY2006 · AI

Mammalian iron-sulfur cluster biogenesis

$1,007,253
Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

$1,007,233
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2017 · CA

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

$1,007,233
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2021 · CA

Novel Vaccine Technology for Chikungunya

$1,007,233
Scott C Weaver · University Of Texas Med Br Galveston · R01 · FY2011 · AI

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

$1,007,233
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2020 · CA

Asthma Clinical Research Network

$1,007,098
William J. Calhoun · University Of Texas Med Br Galveston · U10 · FY2008 · HL

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

$1,007,048
Adam Wayne Carrico · Florida International University · R01 · FY2025 · MH

Obstetric Pharmacology Research Units Network Center at UTMB-Galveston

$1,007,037
Gary D Hankins · University Of Texas Med Br Galveston · U10 · FY2010 · HD

Molecular Biology Of Outer Retina-specific Proteins

$1,007,029
Thomas Redmond · National Eye Institute · ZIA · FY2013 · EY

Synthetic Approaches to Carcinogen-Linked Oligonucleotides

$1,006,869
Carmelo J Rizzo · Vanderbilt University · P01 · FY2013 · CA

Factors Contributing To Immune-Enhanced Disease In The Pathogenesis of RSV

$1,006,825
Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

NIMH Non-Human Primate Research Core

$1,006,444
Philip Wang · National Institute Of Mental Health · ZIC · FY2012 · MH

Cancer-cell specific therapy: photo-immunotherapy

$1,006,345
Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Automated Systems for Detection and Molecular Characterization of Circulating Tum

$1,006,336
Yuling Luo · Advanced Cell Diagnostics, Inc. · R44 · FY2011 · CA

Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)

$1,006,217
David W Crabb · Indiana University Indianapolis · U01 · FY2014 · AA

Novel Small-Molecule Therapies for CF

$1,006,208
Alan S Verkman · University Of California, San Francisco · P30 · FY2017 · DK

TUMOR SENSITIZATION TO PURINE ANALOGS BY E.COLI PNP

$1,006,199
Southern Research Institute · U19 · FY2001 · CA

An Integrated Drug Discovery Platform for Neurodevelopmental Disorders Using Standardized Self-Organizing Human Cerebroids

$1,006,032
Fred Etoc · Rumi Scientific, Inc. · R44 · FY2024 · MH